While ensuring the highest level of health protection for patients.

ChondroCelect is the first product to benefit from the new legal and regulatory framework for advanced therapy medicinal products No 1394/2007). This framework is designed the free circulation of the free movement of advanced medicines within the European Union , to facilitate their access to the EU market and to promote the competitiveness of the European pharmaceutical company in the field, while ensuring the highest level of health protection for patients.

ChondroCelect from TiGenix NV, is a cell – based medicine, which are used to detect defects in the cartilage of the femoral condyle (the end of the femur repaired repaired in the knee.Universal Detection Technology , a developer of early-warning monitoring technologies people people from bioterrorism and other infectious agents health risks and suppliers of counter-terrorism consulting and trainings announced today the test results of to its passive region security sensing, develops by the partnership with sensor Products Instrumentation , a leading supplier of safety sensor. Tests, carried out at an unknown airfield to show the sensor on most precise Human Target Detection System non not on line-of-sight perspective.

Other entries from category "allergy":

Tag Cloud